Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides
Alberto Bresciani(University of Bergamo), Steven J. Harper(Northwestern University), Ilaria Biancofiore(IRBM Science Park), Emanuela Nizi(IRBM Science Park), Federica Ferrigno(IRBM Science Park), Edith Monteagudo(IRBM Science Park), Vincenzo Summa(IRBM Science Park), A Ciammaichella(IRBM Science Park), Ilaria Rossetti(IRBM Science Park), Jesus M. Ontoria(IRBM Science Park), Annalise Di Marco(IRBM Science Park), Simona Ponzi(IRBM Science Park), Maria Veneziano(IRBM Science Park), Alessandra Francone(IRBM Science Park), Paola Pace(IRBM Science Park), Antonella Cellucci(IRBM Science Park), Savina Malancona(IRBM Science Park)
Cited by 32
Related Papers
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
|Cell Death and Differentiation|2020|149
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease
|Journal of Clinical Investigation|2019|101
Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab
|Clinical Cancer Research|2012|79
Proteolytic Activation Cascade of the Netherton Syndrome–Defective Protein, LEKTI, in the Epidermis: Implications for Skin Homeostasis
|Journal of Investigative Dermatology|2011|75
Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening
|PLoS neglected tropical diseases|2018|68